Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CXCL9 associated with sustained virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy: a pilot study.

PloS one - 1 Jan 2013

Lee I-Cheng, Huang Yi-Hsiang, Su Chien-Wei, Wang Yuan-Jen, Huo Teh-Ia, Lee Kuei-Chuan, Lin Han-Chieh

Abstract excerpt

BACKGROUND AND AIMS: There is lack of a practical biomarker to predict sustained virological response (SVR) in chronic hepatitis B (CHB) patients undergoing peginterferon alfa-2a (PEG-IFN). The aim of this pilot study was to identify immunological features associated with SVR. METHODS: Consecutive 74 CHB patients receiving 24 weeks (for hepatitis B e antigen (HBeAg)-positive) or 48 weeks (for HBeAg-negative)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Interferon-alpha

Share to Pilot Projects

Share to Polyethylene Glycols

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 24124595
DOI: 10.1371/journal.pone.0076798
PMCID: PMC3790882

Genes

CXCL9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CXCL9 associated with sustained virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy: a pilot study.PMID 24124595Read ↗

Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B.Semantic proximity Read ↗

CXCL9 and CXCL13 as Predictive Biomarkers for Autoimmune-like Phenotype in Chronic Hepatitis C: Evidence for Viral-Induced Autoimmune Hepatitis TransitionSemantic proximity Read ↗

Association of interferon-gamma inducible protein 10 polymorphism with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B.Semantic proximity Read ↗

High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity.Semantic proximity Read ↗

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.Semantic proximity Read ↗

Association of interferon-γ-induced protein-10 serum levels with virological responses to PEG-interferon-based therapy in hepatitis C virus genotype 1 or 2 chronically infected Chinese patients.Semantic proximity Read ↗

Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients.Semantic proximity Read ↗

CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV.Semantic proximity Read ↗

Innate and Adaptive Immune Responses in Chronic Hepatitis C Virus and Hepatitis B Virus Infection with High Viral LoadsSemantic proximity Read ↗

Deciphering the Significance of Plasma Chemokines as Prognostic Biomarkers in Pegylated IFN-Α-2a /Ribavirin-Treated Chronic Hepatitis C Genotype 4 Patients.Semantic proximity Read ↗

Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of antiviral therapies across different courses of chronic HBV infectionSemantic proximity Read ↗

Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.